Autonomous Synthesis Robot Uses AI to Speed Up Chemical Discovery

Chemists of the University of Amsterdam (UvA) have developed an autonomous chemical synthesis robot with an integrated AI-driven machine learning unit. Dubbed 'RoboChem', the benchtop device can outperform a human chemist in terms of speed and accuracy while also displaying a high level of ingenuity. As the first of its kind, it could significantly accelerate chemical discovery of molecules for pharmaceutical and many other applications. RoboChem's first results were published on 25 January in the journal Science.

RoboChem was developed by the group of Prof. Timothy Noël at the UvA's Van't Hoff Institute for Molecular Sciences. Their paper shows that RoboChem is a precise and reliable chemist that can perform a variety of reactions while producing minimal amounts of waste. Working autonomously around the clock, the system delivers results quickly and tirelessly. Noël: "In a week, we can optimise the synthesis of about ten to twenty molecules. This would take a PhD student several months." The robot not only yields the best reaction conditions, but also provides the settings for scale-up. "This means we can produce quantities that are directly relevant for suppliers to the pharmaceutical industry, for example."

The expertise of the Noël group is in flow chemistry, a novel way of performing chemistry where a system of small, flexible tubes replaces beakers, flasks and other traditional chemistry tools. In RoboChem, a robotic needle carefully collects starting materials and mixes these together in small volumes of just over half a millilitre. These then flow through the tubing system towards the reactor. There, the light from powerful LEDs triggers the molecular conversion by activating a photocatalyst included in the reaction mixture. The flow then continues towards an automated NMR spectrometer that identifies the transformed molecules. These data are fed back in real-time to the computer that controls RoboChem. "This is the brain behind RoboChem," says Noël. "It processes the information using artificial intelligence. We use a machine learning algorithm that autonomously determines which reactions to perform. It always aims for the optimal outcome and constantly refines its understanding of the chemistry."

The group put a lot of effort into substantiating RoboChem's results. All of the molecules now included in the Science paper were isolated and checked manually. Noël says the system has impressed him with its ingenuity: "I have been working on photocatalysis for more than a decade now. Still, RoboChem has shown results that I would not have been able to predict. For instance, it has identified reactions that require only very little light. At times I had to scratch my head to fathom what it had done. You then wonder: would we have done it the same way? In retrospect, you see RoboChem's logic. But I doubt if we would have obtained the same results ourselves. Or not as quickly, at least."

The researchers also used RoboChem to replicate previous research published in four randomly selected papers. They then determined whether Robochem produced the same - or better - results. "In about 80% of the cases, the system produced better yields. For the other 20%, the results were similar," Noël says. "This leaves me with no doubt that an AI-assisted approach will be beneficial to chemical discovery in the broadest possible sense."

According to Noël, the relevance of RoboChem and other 'computerised' chemistry also lies in the generation of high-quality data, which will benefit the future use of AI. "In traditional chemical discovery only a few molecules are thoroughly researched. Results are then extrapolated to seemingly similar molecules. RoboChem produces a complete and comprehensive dataset where all relevant parameters are obtained for each individual molecule. That provides much more insight."

Another feature is that the system also records 'negative' data. In current scientific practice, most published data only reflects successful experiments. "A failed experiment also provides relevant data," says Noël. "But this can only be found in the researchers' handwritten lab notes. These are not published and thus unavailable for AI-powered chemistry. RoboChem will change that, too. I have no doubt that if you want to make breakthroughs in chemistry with AI, you will need these kinds of robots."

Slattery A, Wen Z, Tenblad P, Sanjosé-Orduna J, Pintossi D, den Hartog T, Noël T.
Automated self-optimization, intensification, and scale-up of photocatalysis in flow.
Science. 2024 Jan 26;383(6681):eadj1817. doi: 10.1126/science.adj1817

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...